Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “XERIS PHARMACEUTICALS, INC.”

24 pharma patents match "XERIS PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 24
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 24 pharmaceutical patents matching "XERIS PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

24 results for “XERIS PHARMACEUTICALS, INC.” · 30,257 patents in full index Clear search

  1. US 12377096

    Methods of treating disease with levoketoconazole

    XERIS PHARMACEUTICALS, INC. · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted

  2. US 11964003

    Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

    XERIS PHARMACEUTICALS, INC. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted

  3. US 11957736

    Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

    XERIS PHARMACEUTICALS, INC. · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted

  4. US 11833157

    Precipitation resistant small molecule drug formulations

    XERIS PHARMACEUTICALS, INC. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  5. US 11590205

    Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents

    XERIS PHARMACEUTICALS, INC. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  6. US 11576951

    Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

    XERIS PHARMACEUTICALS, INC. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted

  7. US 11446310

    Stable formulations for parenteral injection of small molecule drugs

    XERIS PHARMACEUTICALS, INC. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  8. US 11129940

    Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes

    XERIS PHARMACEUTICALS, INC. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  9. US 11020403

    Precipitation resistant small molecule drug formulations

    XERIS PHARMACEUTICALS, INC. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted

  10. US 10987399

    Stable formulations for parenteral injection of peptide drugs

    XERIS PHARMACEUTICALS, INC. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted

  11. US 10765683

    Stable formulations for parenteral injection of small molecule drugs

    XERIS PHARMACEUTICALS, INC. · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted

  12. US 10485850

    Methods for producing stable therapeutic formulations in aprotic polar solvents

    XERIS PHARMACEUTICALS, INC. · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted

  13. US 9649364

    Methods for producing stable therapeutic formulations in aprotic polar solvents

    XERIS PHARMACEUTICALS, INC. · Granted May 16, 2017 · Expires May 11, 2037

    granted

  14. US 9642894

    Compositions for rapidly treating severe hypoglycemia

    XERIS PHARMACEUTICALS, INC. · Granted May 9, 2017 · Expires May 4, 2037

    granted

  15. US 9339545

    Stable formulations for parenteral injection of peptide drugs

    XERIS PHARMACEUTICALS, INC. · Granted May 17, 2016 · Expires May 12, 2036

    granted

  16. US 9314424

    Pastes for injection of a therapeutic agent

    XERIS PHARMACEUTICALS, INC. · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  17. US 9302010

    Stable formulations for parenteral injection of peptide drugs

    XERIS PHARMACEUTICALS, INC. · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  18. US 9295724

    Stable formulations for parenteral injection of peptide drugs

    XERIS PHARMACEUTICALS, INC. · Granted Mar 29, 2016 · Expires Mar 24, 2036

    granted

  19. US 9138479

    Formulations for the treatment of diabetes

    XERIS PHARMACEUTICALS, INC. · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  20. US 9125805

    Stable formulations for parenteral injection of small molecule drugs

    XERIS PHARMACEUTICALS, INC. · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  21. US 9018162

    Methods for rapidly treating severe hypoglycemia

    XERIS PHARMACEUTICALS, INC. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  22. US 8790679

    Intracutaneous paste composition

    XERIS PHARMACEUTICALS, INC. · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted

  23. US 8697644

    Stable formulations for parenteral injection of peptide drugs

    XERIS PHARMACEUTICALS, INC. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  24. US 8110209

    Intracutaneous injection

    XERIS PHARMACEUTICALS, INC. · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.